Norepinephrine Bitartrate is Used for increasing blood pressure in adult patients with severe, acute hypotension. It was first introduced by Hospira Inc in its drug Levophed on Approved Prior to Jan 1, 1982. Other drugs containing Norepinephrine Bitartrate are Norepinephrine Bitartrate In 5% Dextrose, Norepinephrine Bitartrate In 0.9% Sodium Chloride. 19 different companies have introduced drugs containing Norepinephrine Bitartrate.

Norepinephrine Bitartrate Patents

Given below is the list of patents protecting Norepinephrine Bitartrate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Norepinephrine Bitartrate In 5% Dextrose	US12097170	Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation	Mar 08, 2041	Baxter Hlthcare Corp
Norepinephrine Bitartrate In 5% Dextrose	US12290494	Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation	Mar 08, 2041	Baxter Hlthcare Corp
Norepinephrine Bitartrate In 0.9% Sodium Chloride	US10888534	Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags	Apr 26, 2039	Inforlife
Norepinephrine Bitartrate In 0.9% Sodium Chloride	US10159657	Norepinephrine compositions and methods therefor	Jan 30, 2038	Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride	US10226436	Norepinephrine compositions and methods therefor	Jan 30, 2038	Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride	US10420735	Norepinephrine compositions and methods therefor	Jan 30, 2038	Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride	US10568850	Norepinephrine compositions and methods therefor	Jan 30, 2038	Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride	US11413259	Norepinephrine compositions and methods therefor	Jan 30, 2038	Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride	US11602508	Norepinephrine compositions and methods therefor	Jan 30, 2038	Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride	US12245996	Norepinephrine compositions and methods therefor	Jan 30, 2038	Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride	US10251848	Process for producing a stable low concentration, injectable solution of noradrenaline	Feb 26, 2035	Inforlife
Norepinephrine Bitartrate In 0.9% Sodium Chloride	USRE49422	Process for producing a stable low concentration, injectable solution of noradrenaline	Feb 26, 2035	Inforlife
Norepinephrine Bitartrate In 0.9% Sodium Chloride	USRE49443	Process for producing a stable low concentration, injectable solution of noradrenaline	Feb 26, 2035	Inforlife

Add above patents to watchlist

Norepinephrine Bitartrate's Family Patents

Full family tree

Norepinephrine Bitartrate Generic API Manufacturers

Several generic applications have been filed for Norepinephrine Bitartrate. The first generic version for Norepinephrine Bitartrate was by Meitheal Pharmaceuticals Inc and was approved on Mar 3, 2003. And the latest generic version is by Biocon Pharma Ltd and was approved on Mar 21, 2025.

Given below is the list of companies who have filed for Norepinephrine Bitartrate generic, along with the locations of their manufacturing plants worldwide.